EVALUATION OF THE EFFECT OF MESENCHYMAL STEM CELLS ON CHEMOTHERAPY RESPONSE FOR NEUROBLASTOMA TREATMENT IN AN EXPERIMENTAL ANIMAL MODEL
S. Aktas, Y. Olgun, H. Evin, P. Ercetin, T. C. Aktas, O. Yilmaz, G. Kirkim, N. Olgun
This study evaluates how mesenchymal stem cells (MSC) affect chemotherapy response and toxicity in a neuroblastoma model, finding that MSC reduces hearing loss from cisplatin without compromising its antitumor effect.
bioRxiv · Nov 9, 2020 · PreprintCancer Biology